These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26801674)

  • 21. Overexpression of NKX6.1 is closely associated with progressive features and predicts unfavorable prognosis in human primary hepatocellular carcinoma.
    Huang LL; Zhang Y; Zhang JX; He LJ; Lai YR; Liao YJ; Tian XP; Deng HX; Liang YJ; Kung HF; Xie D; Zhu SL
    Tumour Biol; 2015 Jun; 36(6):4405-15. PubMed ID: 25596704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular Carcinoma.
    Qi LN; Xiang BD; Wu FX; Ye JZ; Zhong JH; Wang YY; Chen YY; Chen ZS; Ma L; Chen J; Gong WF; Han ZG; Lu Y; Shang JJ; Li LQ
    Cancer Res; 2018 Aug; 78(16):4731-4744. PubMed ID: 29915159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
    Du R; Wu S; Lv X; Fang H; Wu S; Kang J
    J Exp Clin Cancer Res; 2014 Dec; 33(1):105. PubMed ID: 25499255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteinase-activated receptor 2 promotes tumor cell proliferation and metastasis by inducing epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma.
    Sun L; Li PB; Yao YF; Xiu AY; Peng Z; Bai YH; Gao YJ
    World J Gastroenterol; 2018 Mar; 24(10):1120-1133. PubMed ID: 29563756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Profilin 1, negatively regulated by microRNA-19a-3p, serves as a tumor suppressor in human hepatocellular carcinoma.
    Wang Z; Shi Z; Zhang L; Zhang H; Zhang Y
    Pathol Res Pract; 2019 Mar; 215(3):499-505. PubMed ID: 30638858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
    Yu M; Xue H; Wang Y; Shen Q; Jiang Q; Zhang X; Li K; Jia M; Jia J; Xu J; Tian Y
    Int J Oncol; 2017 Mar; 50(3):975-983. PubMed ID: 28098858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glypican-3 promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through ERK signaling pathway.
    Wu Y; Liu H; Weng H; Zhang X; Li P; Fan CL; Li B; Dong PL; Li L; Dooley S; Ding HG
    Int J Oncol; 2015 Mar; 46(3):1275-85. PubMed ID: 25572615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of protocadherin-17 (PCDH-17) promotes metastasis and invasion through hyperactivation of EGFR/MEK/ERK signaling pathway in hepatocellular carcinoma.
    Dang Z; Shangguan J; Zhang C; Hu P; Ren Y; Lv Z; Xiang H; Wang X
    Tumour Biol; 2016 Feb; 37(2):2527-35. PubMed ID: 26386721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition.
    Wang TH; Lin YS; Chen Y; Yeh CT; Huang YL; Hsieh TH; Shieh TM; Hsueh C; Chen TC
    Oncotarget; 2015 Sep; 6(27):23342-57. PubMed ID: 26160837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
    Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
    J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of CD29-ILK-Akt signaling-mediated epithelial-mesenchymal transition of liver epithelial cells and chemoresistance and radioresistance in hepatocellular carcinoma cells.
    Jiang X; Wang J; Zhang K; Tang S; Ren C; Chen Y
    Med Oncol; 2015 May; 32(5):141. PubMed ID: 25805567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cx32 reverses epithelial-mesenchymal transition in doxorubicin-resistant hepatocellular carcinoma.
    Yu M; Han G; Qi B; Wu X
    Oncol Rep; 2017 Apr; 37(4):2121-2128. PubMed ID: 28260043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silencing of IL13RA2 promotes partial epithelial-mesenchymal transition in hepatocellular carcinoma via ERK signaling pathway activation.
    Wang M; Yao R; Wang Y
    FEBS Open Bio; 2020 Feb; 10(2):229-236. PubMed ID: 31823484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ROR-α-1 inhibits the proliferation, invasion, and migration of hepatocellular carcinoma MHCC97H via downregulation of chemokine CXCL5.
    Liu G; Yang ZF; Zhou PY; Zhou C; Guan RY; Sun BY; Fan J; Zhou J; Yi Y; Qiu SJ
    Cytokine; 2020 May; 129():155004. PubMed ID: 32058275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioinformatics analysis of LINC01554 and its co‑expressed genes in hepatocellular carcinoma.
    Li L; Huang K; Lu Z; Zhao H; Li H; Ye Q; Peng G
    Oncol Rep; 2020 Nov; 44(5):2185-2197. PubMed ID: 33000250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TMPRSS4 facilitates epithelial-mesenchymal transition of hepatocellular carcinoma and is a predictive marker for poor prognosis of patients after curative resection.
    Wang CH; Guo ZY; Chen ZT; Zhi XT; Li DK; Dong ZR; Chen ZQ; Hu SY; Li T
    Sci Rep; 2015 Jul; 5():12366. PubMed ID: 26190376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA‑601 serves as a potential tumor suppressor in hepatocellular carcinoma by directly targeting PIK3R3.
    Song Y; He S; Zhuang J; Wang G; Ni J; Zhang S; Ye Y; Xia W
    Mol Med Rep; 2019 Mar; 19(3):2431-2439. PubMed ID: 30664174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of SASH1 Inhibits the Proliferation, Invasion, and EMT in Hepatocarcinoma Cells.
    He P; Zhang HX; Sun CY; Chen CY; Jiang HQ
    Oncol Res; 2016; 24(1):25-32. PubMed ID: 27178819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-187-3p inhibits the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting S100A4.
    Dou C; Liu Z; Xu M; Jia Y; Wang Y; Li Q; Yang W; Zheng X; Tu K; Liu Q
    Cancer Lett; 2016 Oct; 381(2):380-90. PubMed ID: 27544906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
    Qiu G; Lin Y; Zhang H; Wu D
    Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.